Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lorus Therapeutics Inc. -- Ignore unavailable to you. Want to Upgrade?

To: MarcG who wrote (233)	4/5/1999 1:07:00 AM
From: thewiz	Read Replies (1) \| Respond to of 279

Marc, I read over the Lorus and Faulding announcement again and hope you can clarify a point. One point mentioned is that "Virulizin is approved for one indication" in Mexico. What is your interpretation of the above??

To: MarcG who wrote (233)	4/5/1999 5:52:00 PM
From: DaveAu	Read Replies (1) \| Respond to of 279

<<This is a development stage pharma not a major>> So? <<This is common practice for all issues>> Maybe, but I've seen many companies that do release this type of information. IMO, they make better investments. <<You sound more like a MM caught with his pants down than a supporter of Lorus>> I'm not a "supporter" of any company. I'm interested in discussing the merits and the shortcomings of this company. If it matters, I am long on this one with a purchase price of 1.10. You can conclude that that is why I sound disgruntled but there is more to it than that. I often average down if I believe a company is good value but I haven't done so on this one and don't plan to unless management does something to convince me they have a viable plan. They get no cigar from me for this news release. They are way down today (on a big up day for Nasdaq) so it looks like I'm not the only one unimpressed with the big news. BJ